We are live on ! Find out more
RhumbLine Advisers

RhumbLine Advisers Portfolio holdings

AUM $117B
1-Year Est. Return 29.66%
This Fund
S&P 500
This Quarter Est. Return
+17.1%
1 Year Est. Return
+29.66%
3 Year Est. Return
+101.47%
5 Year Est. Return
+137.35%
10 Year Est. Return
+530.92%
AUM
$72.5B
AUM Growth
+$8.64B
Cap. Flow
-$411M
Cap. Flow %
-0.57%
Top 10 Hldgs %
21.89%
Holding
3,099
New
114
Increased
2,324
Reduced
599
Closed
47

Top Sells

Rank Stock Value
1
AAPL icon
Apple
AAPL
+$108M
2
MSFT icon
Microsoft
MSFT
+$73.2M
3
AMZN icon
Amazon
AMZN
+$49.5M
4
GOOG icon
Alphabet (Google) Class C
GOOG
+$27.8M
5
META icon
Meta Platforms (Facebook)
META
+$22.2M

Sector Composition

Rank Sector Weight
1 Technology 23.78%
2 Financials 13.46%
3 Healthcare 13.26%
4 Consumer Discretionary 12.31%
5 Communication Services 9.38%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
OSPN icon
1851
OneSpan
OSPN
$618M
$1.99M ﹤0.01%
96,156
+3,842
+4% +$82.6K
HSTM icon
1852
HealthStream
HSTM
$840M
$1.99M ﹤0.01%
90,937
+9,260
+11% +$186K
ARLO icon
1853
Arlo Technologies
ARLO
$1.65B
$1.98M ﹤0.01%
254,460
+20,652
+9% +$126K
NFBK
1854
DELISTED
Northfield Bancorp
NFBK
$1.98M ﹤0.01%
160,739
+20,339
+14% +$225K
TROX icon
1855
Tronox
TROX
$1.04B
$1.98M ﹤0.01%
135,108
+7,585
+6% +$88.3K
TPIC
1856
DELISTED
TPI Composites
TPIC
$1.97M ﹤0.01%
37,320
-66
-0.2% -$2.64K
DRNA
1857
DELISTED
Dicerna Pharmaceuticals, Inc.
DRNA
$1.96M ﹤0.01%
88,831
-1,103
-1% -$24.3K
CLB icon
1858
Core Laboratories
CLB
$521M
$1.94M ﹤0.01%
73,215
+5,733
+8% +$117K
TVTX icon
1859
Travere Therapeutics
TVTX
$5.78B
$1.94M ﹤0.01%
71,078
+4,456
+7% +$104K
HSII
1860
DELISTED
Heidrick & Struggles
HSII
$1.93M ﹤0.01%
65,818
+7,242
+12% +$182K
KPTI icon
1861
Karyopharm Therapeutics
KPTI
$48M
$1.93M ﹤0.01%
8,314
+200
+2% +$46.3K
MGNX icon
1862
MacroGenics
MGNX
$257M
$1.93M ﹤0.01%
84,424
+10,731
+15% +$247K
PRIM icon
1863
Primoris Services
PRIM
$4.45B
$1.93M ﹤0.01%
69,905
+6,455
+10% +$149K
CMO
1864
DELISTED
Capstead Mortgage Corp.
CMO
$1.93M ﹤0.01%
331,840
+36,577
+12% +$209K
KFRC icon
1865
Kforce
KFRC
$1.06B
$1.92M ﹤0.01%
45,653
-402
-0.9% -$15.9K
PARR icon
1866
Par Pacific Holdings
PARR
$3.32B
$1.92M ﹤0.01%
137,173
+16,952
+14% +$175K
CYH icon
1867
Community Health Systems
CYH
$423M
$1.92M ﹤0.01%
257,752
+14,675
+6% +$104K
RGP icon
1868
Resources Connection
RGP
$145M
$1.91M ﹤0.01%
151,738
+9,975
+7% +$120K
CENX icon
1869
Century Aluminum
CENX
$5.07B
$1.91M ﹤0.01%
172,764
+15,690
+10% +$142K
ICHR icon
1870
Ichor Holdings
ICHR
$2.56B
$1.91M ﹤0.01%
63,224
+4,352
+7% +$123K
YMAB
1871
DELISTED
Y-mAbs Therapeutics
YMAB
$1.91M ﹤0.01%
38,496
+1,941
+5% +$89.8K
BFS
1872
Saul Centers
BFS
$841M
$1.9M ﹤0.01%
59,977
+597
+1% +$17.6K
AGNT
1873
AGNT Inc
AGNT
$734M
$1.89M ﹤0.01%
59,996
+4,944
+9% +$136K
CPF icon
1874
Central Pacific Financial
CPF
$1B
$1.89M ﹤0.01%
99,429
+13,446
+16% +$219K
NMRK icon
1875
Newmark Group
NMRK
$2.63B
$1.89M ﹤0.01%
259,070
+31,834
+14% +$197K

Similar funds

RhumbLine Advisers's Q4 2020 Portfolio in Review

As of Q4 2020, RhumbLine Advisers held 3,099 positions worth $72.5B, up 14% from $63.8B the previous quarter. Its ten largest holdings account for 22% of the portfolio.

RhumbLine Advisers's Q4 2020 filing shows 114 new, 2,324 increased, 599 reduced and 47 closed positions. Its largest new stake was Apartment Income REIT Corp.: 482,605 shares worth $18.5M. The largest sale was Apple, an estimated $108M.

By sector, the portfolio is most concentrated in Technology at 24% of assets, down from 24% a quarter earlier, followed by Financials and Healthcare.

  • RhumbLine Advisers's largest Q4 2020 buy was Apartment Income REIT Corp.: 482,605 shares worth $18.5M.
  • RhumbLine Advisers added most to Tesla in Q4 2020, an estimated $278M increase.
  • RhumbLine Advisers's biggest Q4 2020 reduction was Apple, cutting an estimated $108M.
  • RhumbLine Advisers fully exited Immunomedics Inc in Q4 2020, selling an estimated $20.4M.
  • RhumbLine Advisers's ten largest holdings make up 22% of its $72.5B portfolio in Q4 2020.
  • RhumbLine Advisers opened 114 new positions and closed 47 in Q4 2020.
  • RhumbLine Advisers's portfolio value rose 14% quarter-over-quarter to $72.5B.

Based on RhumbLine Advisers's 13F filing for Q4 2020, filed 10 Feb 2021.